Impact of treatment with dimethyl fumarate on sleep quality in patients with relapsing-remitting multiple sclerosis: A multicentre Italian wearable tracker study.
Giancarlo ComiLetizia LeocaniLuigi Ferini-StrambiMarta RadaelliGloria D CostaRoberta LanzilloGiacomo LusValentina BianchiSebastiano TraccisFioravante CaponeLuigi Me GrimaldiGiuseppe SalemiAlessandra CardilloValentina Zipolinull nullPublished in: Multiple sclerosis journal - experimental, translational and clinical (2023)
In patients with relapsing-remitting multiple sclerosis, the treatment with dimethyl fumarate was associated with improvements in patient-reported quality of sleep. Further randomised clinical trials are needed to confirm the benefits of long-term treatment with dimethyl fumarate.